| Literature DB >> 35723331 |
Alan H Feiveson1, Stephanie S Krieger2, Gudrun von Scheven3, Brian E Crucian1, Alexander Bürkle3, Alexander C Stahn4,5, Honglu Wu1, María Moreno-Villanueva1,6.
Abstract
The effect of confined and isolated experience on astronauts' health is an important factor to consider for future space exploration missions. The more confined and isolated humans are, the more likely they are to develop negative behavioral or cognitive conditions such as a mood decline, sleep disorder, depression, fatigue and/or physiological problems associated with chronic stress. Molecular mediators of chronic stress, such as cytokines, stress hormones or reactive oxygen species (ROS) are known to induce cellular damage including damage to the DNA. In view of the growing evidence of chronic stress-induced DNA damage, we conducted an explorative study and measured DNA strand breaks in 20 healthy adults. The participants were grouped into five teams (missions). Each team was composed of four participants, who spent 45 days in isolation and confinement in NASA's Human Exploration Research Analog (HERA). Endogenous DNA integrity, ex-vivo radiation-induced DNA damage and the rates of DNA repair were assessed every week. Our results show a high inter-individual variability as well as differences between the missions, which cannot be explained by inter-individual variability alone. The ages and sex of the participants did not appear to influence the results.Entities:
Keywords: DNA damage; radiation; space environment; stress
Year: 2022 PMID: 35723331 PMCID: PMC8929106 DOI: 10.3390/cimb44020046
Source DB: PubMed Journal: Curr Issues Mol Biol ISSN: 1467-3037 Impact factor: 2.976
Figure 1Percent changes in DNAI pre-irradiation (pre rad.) median relative to DNAI baseline (day C-10); # denotes adjusted p < 0.1 for false-discovery rates (FDRs). Error bars represent 95% CI. (a–d) are missions 1, 4, 3 and 5 respectively.
Figure 2Percent difference between irradiation (post rad.) effect on DNAI median at each session relative to irradiation effect at baseline (day C-10). Irradiation effect is defined as the ratio of median DNAI post irradiation to DNAI median pre-irradiation. # denotes adjusted p < 0.1 for false-discovery rates (FDRs). Error bars represent 95% CI. (a–d) are missions 1, 4, 3 and 5 respectively.
Figure 3Difference in mean ADRR (DNAI/hr) between each session and baseline ADRR (day C 10). # denotes adj p < 0.1 for false-discovery rates (FDRs). Error bars represent 95% CI. (a–d) are missions 1, 4, 3 and 5 respectively.
HERA Sessions (=mission days).
| HERA Session | Day |
|---|---|
| 1 | pre-confinement |
| 2 | Day 3 |
| 3 | Day 10 |
| 4 | Day 17 |
| 5 | Day 24 |
| 6 | Day 31 |
| 7 | Day 38 |
| 8 | Day 45 |
| 9 | Recovery Day 1 |
| 10 | Recovery Day 7 |
Sub-subsample characteristics–Viability assessment and 7 experimental conditions for assessing DNAI. Irradiation was for 380 sec. at a dose rate of 0.59 Gy/min. Total dose = 3.73 Gy.
| Sub-Subsample | Exp Condition | X-ray Radiation | Incubation Time (min) |
|---|---|---|---|
| 1 | Viability | none | none |
| 2 | Pre-irradiation | none | none |
| 3 | Time Point 1 | 3.73 Gy | 0 |
| 4 | Time Point 2 | 3.73 Gy | 15 |
| 5 | Time Point 3 | 3.73 Gy | 30 |
| 6 | Time Point 4 | 3.73 Gy | 45 |
| 7 | Time Point 5 | 3.73 Gy | 60 |
| 8 | Time Point 6 | 3.73 Gy | 75 |
Allocation of sub-samples to fluorescence microplates.
| Plate | Subjects | Mission | Session | # of Sub-Samples |
|---|---|---|---|---|
| 1 | 1,2 | 1 | Baseline | 64 * |
| 2 | 3,4 | 1 | Baseline | 64 |
| 3 | 5,6 | 2 | Baseline | 64 |
| 4 | 7,8 | 2 | Baseline | 64 |
| 5 | 9,10 | 3 | Baseline | 64 |
| 6 | 11,12 | 3 | Baseline | 64 |
| 7 | 13,14 | 4 | Baseline | 64 |
| 8 | 15,16 | 4 | Baseline | 64 |
| 9 | 17,18 | 5 | Baseline | 64 |
| 10 | 19,20 | 5 | Baseline | 64 |
| 11 | 1,2 | 1 | Day 3 | 64 |
| 12 | 3,4 | 1 | Day 3 | 64 |
| 13 | 5,6 | 2 | Day 3 | 64 |
| 14 | 7,8 | 2 | Day 3 | 64 |
| 15 | 9,10 | 3 | Day 3 | 64 |
| 16 | 11,12 | 3 | Day 3 | 64 |
| 17 | 13,14 | 4 | Day 3 | 64 |
| 18 | 15,16 | 4 | Day 3 | 64 |
| 19 | 17,18 | 5 | Day 3 | 64 |
| 20 | 19,20 | 5 | Day 3 | 64 |
| Plates 21–30: same as above, except session is Day 10 | ||||
| Plates 31–40: same as above, except session is Day 17 | ||||
| Plates 41–50: same as above, except session is Day 24 | ||||
| Plates 51–60: same as above, except session is Day 31 | ||||
| Plates 61–70: same as above, except session is Day 38 | ||||
| Plates 71–80: same as above, except session is Day 45 | ||||
| Plates 81–90: same as above, except session is R + 1 | ||||
| Plates 91–100: same as above, except session is R + 7 | ||||
* 4 reps × 8 experimental conditions × 2 subjects = 64 subsamples.